Rafael Holdings, Inc. is > 10% Shareholder of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 9.03 Million shares of CYTH, which is worth approximately $6.59 Million. The most recent transaction as insider was on Oct 20, 2023, when has been sold 2,514,970 shares (Common Stock) at a price of $0.71 per share, resulting in proceeds of $1,785,628. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.03M
0% 3M change
0% 12M change
Total Value Held $6.59 Million

Rafael Holdings, Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2023
BUY
Exercise of in-the-money or at-the-money derivatives securities
$1,785,628 $0.71 p/Share
2,514,970 Added 21.78%
9,029,940 Common Stock
Aug 01 2023
BUY
Open market or private purchase
$5,000,000 $1.25 p/Share
4,000,000 Added 38.04%
6,514,970 Common Stock, par valu...
RHI

Rafael Holdings, Inc.

> 10% Shareholder
Newark, NJ

Track Institutional and Insider Activities on CYTH

Follow Cyclo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

News

Receive news related to Cyclo Therapeutics, Inc.

Track Activities on CYTH